腎造口設備市場規模、佔有率和成長分析（按產品、最終用戶和地區）- 產業預測 2025-2032

2023 年全球腎造口設備市場規模價值 13 億美元，預計將從 2024 年的 14.1 億美元成長到 2032 年的 27.3 億美元，預測期內（2025-2032 年）的複合年成長率為 8.6%。

腎造口設備市場正在經歷顯著成長，原因是以尿道結石，影響了全球12％的人口，並且預計腎癌病例數也會增加，到2023年美國預計將有81,800例新病例。腎臟疾病的激增推動了對腎造口設備的需求，尤其是對於因癌症而面臨閉尿症的患者。另一個市場動態是微創手術（MIS）的趨勢。這些技術比傳統手術具有顯著的優勢，包括更短的恢復時間和降低併發症的風險。儘管成長前景良好，但替代治療方案和相關風險等挑戰可能會阻礙市場擴張，在製定策略時需要仔細考慮這些因素。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 監管格局
• 案例研究
• 技術進步

腎造口設備市場規模（依產品及複合年成長率） (2025-2032)

• 市場概況
• 導管導引線
• 引流管
• 腎造口導管
• 鞘套擴張器
• 其他

腎造口設備市場規模（依最終用戶和複合年成長率） (2025-2032)

• 市場概況
• 醫院
• 急診室
• 門診手術中心（ASC）
• 其他

腎造口設備市場規模（按地區）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Boston Scientific Corporation（United States）
• Teleflex Incorporated（United States）
• Becton, Dickinson and Company（United States）
• B. Braun SE（Germany）
• Cook Medical Incorporated（United States）
• Coloplast Group（Denmark）
• Olympus Corporation（Japan）
• Medtronic plc（Ireland）
• AngioDynamics Inc.（United States）
• Envaste Limited（United Kingdom）
• Medi-Globe GmbH（Germany）
• UROMED Kurt Drews KG（Germany）
• ROCAMED（France）
• Amecath（Egypt）
• SURGIMEDIK（India）
• Well Lead Medical Co., Ltd.（China）
• TROGE MEDICAL GmbH（Germany）
• Porges SA（France）
• Allium Medical Solutions Ltd.（Israel）

結論和建議

Global Nephrostomy Device Market size was valued at USD 1.3 billion in 2023 and is poised to grow from USD 1.41 billion in 2024 to USD 2.73 billion by 2032, growing at a CAGR of 8.6% during the forecast period (2025-2032).

The nephrostomy devices market is experiencing significant growth driven by the increasing prevalence of kidney disorders, notably urolithiasis affecting 12% of the global population, and the forecasted rise in kidney cancer cases, with an estimated 81,800 new instances in the U.S. for 2023. This surge in kidney disease incidences fuels demand for nephrostomy devices, especially for patients facing urinary blockages due to cancer. Additionally, the trend towards minimally invasive surgical procedures (MIS) is shaping market dynamics, as these techniques provide substantial benefits over traditional surgery, including shorter recovery times and lower risk of complications. Despite favorable growth prospects, challenges such as alternative treatment options and associated risks may impede market expansion, necessitating careful consideration of these factors in strategic planning.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nephrostomy Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nephrostomy Device Market Segmental Analysis

Global Nephrostomy Device Market is segmented by Product, End User and region. Based on Product, the market is segmented into Guidewires, Drainage Tubes, Nephrostomy Catheters, Sheath Dilators and Others. Based on End User, the market is segmented into Hospital, Emergency Clinics, Ambulatory Surgical Centers (ASCs) and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nephrostomy Device Market

The global nephrostomy device market is significantly driven by ongoing technological advancements that enhance the performance and safety of these medical devices. Innovations such as superior catheter materials, state-of-the-art imaging techniques for precise placement, and advanced drainage systems have markedly improved the efficacy of nephrostomy procedures. As healthcare providers increasingly prioritize the adoption of cutting-edge, efficient devices to optimize patient outcomes, the demand for these innovative nephrostomy solutions continues to rise. This trend highlights the importance of technological evolution in propelling market growth and meeting the evolving needs of medical professionals and patients alike.

Restraints in the Global Nephrostomy Device Market

The global nephrostomy device market faces significant restraints primarily due to the high costs associated with these devices. The expense goes beyond the price of the nephrostomy devices themselves, as it also encompasses necessary consumables and accessories integral to the procedure. This financial burden can hinder the adoption of these devices in various healthcare environments and regions, particularly in facilities with constrained budgets. Additionally, patients experiencing financial difficulties may find it challenging to afford the treatment, further limiting market growth and accessibility. As a result, the high costs remain a crucial obstacle for widespread utilization of nephrostomy devices.

Market Trends of the Global Nephrostomy Device Market

The Global Nephrostomy Device market is experiencing a notable shift towards disposable nephrostomy devices, driven by their clear advantages over traditional reusable options. The increased emphasis on patient safety in healthcare settings has led to a rising adoption of these single-use devices, as they significantly reduce the risks associated with cross-contamination and infection transmission. Furthermore, the convenience and ease of use offered by disposable devices streamline clinical workflows, minimizing the complexities associated with reprocessing and sterilization. This trend indicates a market evolution, with healthcare facilities prioritizing safety and efficiency, thereby enhancing overall patient care and outcomes.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies
• Technological Advancement

Global Nephrostomy Device Market Size by Product & CAGR (2025-2032)

• Market Overview
• Guidewires
• Drainage Tubes
• Nephrostomy Catheters
• Sheath Dilators
• Others

Global Nephrostomy Device Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospital
• Emergency Clinics
• Ambulatory Surgical Centers (ASCs)
• Others

Global Nephrostomy Device Market Size & CAGR (2025-2032)

• North America (Product, End User)
  • US
  • Canada
• Europe (Product, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun SE (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Coloplast Group (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Olympus Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AngioDynamics Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Envaste Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medi-Globe GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• UROMED Kurt Drews KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ROCAMED (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amecath (Egypt)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SURGIMEDIK (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Well Lead Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TROGE MEDICAL GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Porges SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allium Medical Solutions Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations